Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint

British Journal of Rheumatology

Volumn 35, Issue 6, 1996, Pages 553-559

  Johansen, J S ^a   Hvolris, J ^a   Hansen, M ^a   Backer, V ^b   Lorenzen, I ^a   Price, P A ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biochemical markers; Osteoarthritis

Indexed keywords

C REACTIVE PROTEIN; CHITINASE; COLLAGEN TYPE 3; GLYCOPROTEIN; MARKER; PROCOLLAGEN; SECRETORY PROTEIN; UNCLASSIFIED DRUG; YKL 40;

ADOLESCENT; ADULT; AGE; AMINO ACID SEQUENCE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; HUMAN EXPERIMENT; KNEE INJURY; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FAMILY; SYNOVIAL FLUID LEVEL; SYNOVIOCYTE; SYNOVITIS;

EID: 0029924794     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/35.6.553     Document Type: Article

References (14)

1. Johansen JS, Jensen HS, Price PA. A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol 1993;32:949-55.
2. Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondro- cytes and synovial cells, is 'a mammalian member of 'a chitinase protein family. J Biol Chem 1993;268: 25803-10.
3. Rejman JJ, Hurley WL. Isolation and characterization of a novel 39 kilodalton whey protein from bovine mammary secretions collected during the nonlactating period. Biochem Biophys Res Commun 1988;150:329-34.
4. Johansen JS, Williamson MK, Rice JS, Price PA. Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res 1992;7:501-12.
5. Nyirkos P, Golds EE. Human synovial cells secrete a 39 kDa protein similar to a bovine mammary protein expressed during the non-lactating period. Biochem J 1990;268:265-8.
6. Backer V, Dirksen A, Bach-Mortensen N, Hansen KK, Laursen EM, Wejndelbpe D. The distribution of bronchial responsivejness to histamine and exercise in 527 children and adolescents. J Allergy Clin Immunol 1991;88:68-76.
7. Risteli J, Niemi S, Trivedi P, Mäentausta; O, Mowat AP, Risteli L. Rapid : equilibrium radioilinnunoassay for the amirio-terminal propeptide, of human type III procollagen.: Clin Chem 1988;34:715-8.
8. Poole AR. Immunochemical markers of joint inflammation, skeletal damage and repair: where are we now? Ann Rheum Dis :1994;53:3-5.
9. Heinegård D, Saxne T. Molecular markers of processes in cartilage in joint disease. Br J Rheumatol 1991; 30(suppl. 1):21-4.
10. Johansen JS, Hansen M, Hørslev-Petersen K, Lorenzen: I, Price PA. Plasma; YKL-40 concentrations in patients with rheumatoid arthritis. Pulse treatment with methylprednisolone. In: FECTS Meeting, Davos, 1992 (abstract).
11. Shinmei M, Kobayashi T, Yoshihara Y, Samura A. Significance of the levels of carboxy terminal type II procollagen peptide, chondroitin sulfate isomers, tissue inhibitor of metalloproteinases and metalloproteinases in osteoarthritis joint fluid. J Rheumatol 1995;22(suppl. 43):78-81.
12. Clark IM, Powell LK, Ramsey S, Hazleman BL, Cawston TE. The measurement of collagenase, tissue inhibitor of inetalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and: rhematoid arthritis. Arthritis Rheum 1993;36:372-9.
13. Hørslev-Petersen K, Saxne T, Haar D et al. The aminoterminal-type-III procollagen peptide and proteoglycans in serum and synovial fluid of patients with rheumatoid arthritis or reactive arthritis. Rheumatol Int 1988;8:1-9.
14. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-54.